AU6388896A - Butenolide endothelin antagonists - Google Patents
Butenolide endothelin antagonistsInfo
- Publication number
- AU6388896A AU6388896A AU63888/96A AU6388896A AU6388896A AU 6388896 A AU6388896 A AU 6388896A AU 63888/96 A AU63888/96 A AU 63888/96A AU 6388896 A AU6388896 A AU 6388896A AU 6388896 A AU6388896 A AU 6388896A
- Authority
- AU
- Australia
- Prior art keywords
- butenolide
- endothelin antagonists
- endothelin
- antagonists
- butenolide endothelin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90495P | 1995-07-06 | 1995-07-06 | |
US000904 | 1995-07-06 | ||
PCT/US1996/010651 WO1997002265A1 (en) | 1995-07-06 | 1996-06-21 | Butenolide endothelin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6388896A true AU6388896A (en) | 1997-02-05 |
Family
ID=21693513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63888/96A Abandoned AU6388896A (en) | 1995-07-06 | 1996-06-21 | Butenolide endothelin antagonists |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6388896A (en) |
WO (1) | WO1997002265A1 (en) |
ZA (1) | ZA965754B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297274B1 (en) * | 1996-04-10 | 2001-10-02 | Warner-Lambert Company | Nonpeptide endothelin antagonists with increased water solubility |
AU1991197A (en) * | 1996-04-10 | 1997-10-29 | Warner-Lambert Company | Endothelin antagonists with ether-linked groups |
DE19712141A1 (en) * | 1997-03-22 | 1998-09-24 | Merck Patent Gmbh | Endothelin receptor antagonists |
WO1999052888A1 (en) * | 1998-04-08 | 1999-10-21 | Washington Odur Ayuko | Butenolide derivatives as anti-cancer agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05178706A (en) * | 1991-12-27 | 1993-07-20 | Sumitomo Chem Co Ltd | Repellent for harmful arthropod |
CZ40996A3 (en) * | 1993-08-19 | 1996-09-11 | Warner Lambert Co | Substituted derivatives of 2(5h) furanone, 2(5h)-thiophenone or 2(5h) pyrrole and and pharmaceutical composition based thereon |
-
1996
- 1996-06-21 AU AU63888/96A patent/AU6388896A/en not_active Abandoned
- 1996-06-21 WO PCT/US1996/010651 patent/WO1997002265A1/en active Application Filing
- 1996-07-05 ZA ZA965754A patent/ZA965754B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA965754B (en) | 1997-01-27 |
WO1997002265A1 (en) | 1997-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6810596A (en) | Substituted biphenylsulfonamide endothelin antagonists | |
AU5333596A (en) | 3-benzylamino-2-phenylpiperidines as neurokinin antagonists | |
AU679712B2 (en) | Endothelin antagonists | |
AU680522B2 (en) | Sulfonamide endothelin antagonists | |
AU4803996A (en) | Endothelin receptor antagonists | |
AU5840396A (en) | N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists | |
AU7694496A (en) | Endothelin receptor antagonists | |
HU9600256D0 (en) | Substituted diphenyl-sulfonamides, antagonists of endothelin | |
AU4900096A (en) | Task chair | |
AU6304196A (en) | Substituted cyanophenyluracils | |
AU4331496A (en) | Substituted biphenyl sulfonamide endothelin antagonists | |
AU6856796A (en) | Des-arg9-bk antagonists | |
AU4778296A (en) | Fluoropolymer compositions | |
AU7528696A (en) | Muscarine antagonists | |
AU6194396A (en) | Bacteriocin | |
AU6603996A (en) | Furanone endothelin antagonists | |
AU2529297A (en) | Ketoacid endothelin antagonists | |
AU7478496A (en) | Muscarine antagonists | |
AU6764596A (en) | Endothelin receptor antagonists | |
AU6060796A (en) | Endothelin receptor antagonists | |
AU6079296A (en) | Endothelin receptor antagonists | |
AU6304396A (en) | Substituted carbonylaminophenyluracils | |
AU6388896A (en) | Butenolide endothelin antagonists | |
AU6200296A (en) | Endothelin receptor antagonists | |
AU1867097A (en) | Novel LH-RH antagonists having improved action |